- Liu, Kevin;
- Chen, Angela;
- Xiong, Xiaochen;
- Curtis, Matthew;
- Martin, Renata;
- Raftry, Brian;
- Ng, Chun;
- Vogel, Uwe;
- Lander, Angelika;
- Lesch, Benjamin;
- Fowler, Jonas;
- Holman, Alyssa;
- Chai, Timothy;
- Vijayakumar, Siva;
- Suchy, Fabian;
- Nishimura, Toshinobu;
- Bhadury, Joydeep;
- Porteus, Matthew;
- Nakauchi, Hiromitsu;
- Cheung, Christine;
- George, Steven;
- Red-Horse, Kristy;
- Prescott, Joseph;
- Loh, Kyle;
- Ang, Lay;
- Nguyen, Alana
Stem cell research endeavors to generate specific subtypes of classically defined cell types. Here, we generate >90% pure human artery or vein endothelial cells from pluripotent stem cells within 3-4 days. We specified artery cells by inhibiting vein-specifying signals and vice versa. These cells modeled viral infection of human vasculature by Nipah and Hendra viruses, which are extraordinarily deadly (∼57%-59% fatality rate) and require biosafety-level-4 containment. Generating pure populations of artery and vein cells highlighted that Nipah and Hendra viruses preferentially infected arteries; arteries expressed higher levels of their viral-entry receptor. Virally infected artery cells fused into syncytia containing up to 23 nuclei, which rapidly died. Despite infecting arteries and occupying ∼6%-17% of their transcriptome, Nipah and Hendra largely eluded innate immune detection, minimally eliciting interferon signaling. We thus efficiently generate artery and vein cells, introduce stem-cell-based toolkits for biosafety-level-4 virology, and explore the arterial tropism and cellular effects of Nipah and Hendra viruses.